| INTRODUCTION
Acute coronary syndromes (ACS) account for a large percentage of the cardiovascular disease burden and their early diagnosis and risk stratification is an emerging area of interest. [1] [2] [3] [4] ACS refers to a spectrum of clinical presentations that include ST-segment elevation myocardial infarction (STEMI), non-ST-segment elevation myocardial infarction (NSTEMI), and unstable angina. NSTEMI is currently the most frequent manifestation of ACS and represents the largest group of patients to undergo percutaneous coronary intervention (PCI).
Despite advances in medical and interventional treatments, the morbidity and mortality of NSTEMI patients remains high. 5 Early invasive strategy with PCI has shown better clinical and angiographic outcomes in high risk patients with NSTEMI than conservative management or late PCI. 6 In this respect, there is a large percentage of patients with total occlusion (TO) of the culprit artery, diagnosed angiographically, presenting with NSTEMI. 7, 8 Recent findings suggest that NSTEMI patients with TO of the culprit artery are at an increased risk of all-cause mortality and major adverse cardiac events. 9, 10 It is difficult to predict TO of the culprit artery in NSTEMI patients due to the lack of classic electrocardiograms (ECG) findings. Attempts have been made to find a marker that reliably predicts the presence of TO in patients with non-ST-segment acute coronary syndrome (NSTE-ACS)-though without success. In this study, we evaluate the capacity of high-sensitivity cardiac troponin T (hs-cTnT) to predict acute TO of a coronary artery in patients presenting with NSTE-ACS. 
| Study outcomes
The primary outcome was to assess the diagnostic accuracy of hscTnT to predict acute TO in patients with NSTE-ACS.
| Diagnostic adjudication
The final diagnosis was adjudicated for all patients by independent cardiologists, with discrepancies resolved until a consensus was 
| Data collection and follow-up
The baseline demographics, type of presentation, and hospital outcomes were recorded. All available clinic charts, (ECG, holter monitors, and cardiac imaging were reviewed. All the patients included in this study were followed-up during hospitalization and evaluated for the presence of myocardial infarction, recurrent angina, stroke, and allcause mortality.
| Blood sampling and laboratory methods
Venous blood samples were drawn upon arrival to the emergency department via a peripheral venous line and immediately processed.
The Elecsys Troponin T-high sensitive assay (Roche Diagnostics, Risch-Rotkreuz, Switzerland) was used to measure hs-cTnT concentrations with a limit of blank and limit of detection at 3 and 5 ng/L respectively, an imprecision corresponding to 10% coefficient of variation at 13 ng/L, and the 99th percentile upper reference limit from healthy individuals defined at 14 ng/L. 11 
| Determination of coronary occlusion
The type of coronary artery lesion was determined according to the American College of Cardiology/American Heart Association (ACC/AHA) classification. 12 The culprit vessel was identified based on was used to quantify the diagnostic accuracy of the study endpoint.
Univariate and multivariate logistic regressions were used to assess the predictive accuracy of hs-cTnT to predict acute TO. A two-sided P-value of less than 0.05 was considered statistically significant.
| RESULTS
A total of 1011 patients were identified who met the inclusion/exclusion criteria. The mean age was 67.12 SD 13.18 years, 74.1% were male, 26.7% had a history of coronary artery disease, and 8.9% had undergone coronary artery bypass graft surgery ( Table 1 ). The adjudicated diagnosis was NSTEMI in 608 (60.1%) patients and unstable angina in 403 (39.8%) patients. The median Global Registry of Acute Coronary Events score (GRACE) risk score of the population was 118 (IQR: 105-131) and the median TIMI risk score was 3 (range: 2-4). The median GRACE risk score was significantly higher in the TO group of patients (131 vs 117; P = 0.032) ( Table 2 ). The median hospital stay was 4 (IQR: 3-5.3) days.
In-hospital adverse events included recurrent angina (4.5%), myocardial reinfarction (3.5%), stroke (0.4%), bleeding (6.3%), arrhythmias (2.0%), and acute kidney failure (4.4%). In-hospital adverse events stratified by patients with vs without acute TO are summarized in Table 3 . During hospitalization, 8% of the patients required myocardial revascularization surgery.
Angiographic parameters are summarized in Table 4 additional information. Coronary angiography identified 74 (7.3%) patients with acute TO. Of these, 40 (54%) patients had TO of the circumflex artery or its main branches, 25 (34%) patients had TO of the right coronary artery, and 9 (12%) patients had TO of the anterior descending artery.
The total mortality was 1.3% (6 patients in TO-group and 8 patients in non-TO group).
The global median hs-cTnT concentration on admission was 
| DISCUSSION
In a retrospective cohort study of patients with NSTE-ACS, we have demonstrated that hs-cTnT can be a useful marker of predicting the presence of acute TO. We report a number of clinically relevant findings. First, hs-cTnT concentrations were significantly higher in patients with acute TO and that hs-cTnT was an independent predictor of acute TO. Second, a cutoff value of 1006 ng/L hs-cTnT showed good accuracy for the diagnosis of acute TO.
The prevalence of acute coronary occlusions in NSTEMI patients varies from 19% to 30%. 13 In our study, the prevalence of acute occlusions was 7.3%, which could be due to the fact that our population was at a lower risk and included unstable angina patients than the other published series. In Khan et al's meta-analysis to estimate the difference in outcomes between TO and non-TO patients with NSTEMI, 9 the right coronary artery was occluded in most cases (40%)
followed by the circumflex artery (33%). In our study, the circumflex artery was the most commonly involved vessel. Abbreviation: TO, total occlusion.
FIGURE 1
Receiver operating characteristic (ROC) curve for highsensitivity cardiac troponin T (hs-cTnT) and acute total occlusion (TO)
Multiple studies have reported short and long-term adverse
